A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS)

NCT04320316 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Epidermal Nevus Syndrome

Interventions

DRUG: Crysvita (burosumab-twza) Treatment

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]